Skip to main content
. 2016 Nov 5;129(21):2530–2534. doi: 10.4103/0366-6999.192781

Table 2.

Incidence of delayed excretion of MTX according to gender and age

Items Total number of Patients (N = 1277) Patients with delayed MTX excretion (n = 79), n (%) Patients with severe delayed MTX excretion (n = 11), n (%)
Gender
 Male 821 43 (5.24) 3 (0.37)
 Female 456 36 (7.89) 8 (1.75)
χ2 3.57 5.10
P 0.059 0.024
Age (years)
 ≤14 512 27 (5.27) 8 (1.56)
 >14 765 52 (6.80) 3 (0.39)
χ2 1.23 1231.62
P 0.268 <0.001

–: Not applicable; MTX: Methotrexate.